Genetic Variation in Background Mucosa Across Different Grades of Chronic Esophagitis
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.70129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Takuya Ohashi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Esophagitis, Mutation, Esophageal Neoplasms, Esophageal Mucosa. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background and Aim The risk of cancer in chronic esophagitis varies by the number of Lugol's voiding lesions (LVLs). However, how these mutations differ by LVLs grade remains unclear. We aimed to clarify the genetic characteristics of the background mucosa by LVLs grade with a history of endoscopic treatment for esophageal squamous cell carcinoma (ESCC) or squamous dysplasia (SD).
Methods
A total of 34 patients (28 ESCC, 6 SD) were classified by LVLs grade. Tissues from ESCC/SD and background mucosa were taken endoscopically, and DNA was extracted. Somatic mutations were identified in the esophageal cancer panel. For each mutation, putative drivers were identified by OncoKB, and the gene mutation patterns were compared among the grades.
Results
There were LVLs grade B/C = 14/20 cases. Somatic mutation of TP53 was found significantly more frequently in the LVLs than in the background mucosa (88.2% vs. 64.7%, p = 0.043, Fisher's exact test). Somatic mutations of NOTCH1, including putative drivers, were more frequent in the background mucosa than in ESCC/SD (82.3% vs. 44.1%, p = 0.002, Fisher's exact test). There was no significant difference in the percentage of putative drivers of TP53 and NOTCH1 in the background mucosa by LVLs grade B/C (50.0% vs. 35.0%, p = 0.487; 7.1% vs. 5.0%, p = 1.000, Fisher's exact test).
Conclusion
Regardless of LVLs grade, the background mucosa of patients with chronic esophagitis who already had ESCC or SD had already accumulated the same level of TP53 gene mutations. Even patients with LVLs grade B chronic esophagitis should undergo regular endoscopic examination for early detection of ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Genome Analysis Center, Yamanashi Prefectural Central Hospital, Kofu, Japan.
- Division of Clinical Genetics and Proteomics, Department of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
- Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Tokyo University, Tokyo, Japan.
ORCID-Profile: Takuya Ohashi, Kenichiro Okimoto, Tsubasa Ishikawa, Tomoaki Matsumura
Zitieren
APA
Ohashi, T., Okimoto, K., Kaneko, T., Akizue, N., Hirotsu, Y., Amemiya, K., Krosugi, A., Ishikawa, T., Ohta, Y., Taida, T., Matsumura, T., Nishimura, M., Matsushita, K., Mochizuki, H., Matusaka, K., Ikeda, J. I., Kato, J., & Omata, M. (2025). Genetic Variation in Background Mucosa Across Different Grades of Chronic Esophagitis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70129
Vancouver
Ohashi T, Okimoto K, Kaneko T, Akizue N, Hirotsu Y, Amemiya K, et al. Genetic Variation in Background Mucosa Across Different Grades of Chronic Esophagitis. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70129
BibTeX
@article{Ohashi2025,
author = {Ohashi, Takuya and Okimoto, Kenichiro and Kaneko, Tatsuya and Akizue, Naoki and Hirotsu, Yosuke and Amemiya, Kenji and Krosugi, Akane and Ishikawa, Tsubasa and Ohta, Yuki and Taida, Takashi and Matsumura, Tomoaki and Nishimura, Motoi and Matsushita, Kazuyuki and Mochizuki, Hitoshi and Matusaka, Keisuke and Ikeda, Jun-Ichiro and Kato, Jun and Omata, Masao},
title = {Genetic Variation in Background Mucosa Across Different Grades of Chronic Esophagitis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.70129}
}
EUVIMED